Multipass Treatment of Photodamage Using the Pulse Dye Laser
Background. Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an option in the treatment of photodamage. Although improvements to skin texture are generally modest when compared with ablative resur...
Saved in:
Published in | Dermatologic surgery Vol. 29; no. 7; pp. 686 - 691 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Inc
01.07.2003
by the American Society for Dermatologic Surgery, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background. Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an option in the treatment of photodamage. Although improvements to skin texture are generally modest when compared with ablative resurfacing, PDL offers a treatment with few side effects. A number of methods have been proposed in an effort to improve treatment outcomes. These range from single, low‐fluence treatment with no purpura to multiple passes and treatment sessions as well as purpuric doses.
Objective. To evaluate several of the PDL treatment methods to improve photorejuvenation outcomes while limiting the risk of side effects.
Methods. Twenty patients with photodamage were separated into two groups. Each group received a series of four single‐pass treatments or four double‐pass treatments at 2‐week intervals. Treatments were done using a 595‐nm PDL (PhotoGenica V‐Star) and a 585‐nm PDL (PhotoGenica V) at a pulse duration of 0.5 ms and a 10‐mm handpiece. Treatment fluences were maintained below the individual's purpuric threshold, ranging from 3 to 4 J/cm2. Photos were taken before treatment and during follow‐up. Efficacy of treatment was based on subjective grading of photos and by patient self‐reporting.
Results. Multiple treatments resulted in improvements to skin tone and texture, including a reduction in the appearance of rhytids and, in particular, improved pigmentary evenness. There was no significant difference between laser or treatment methods. No side effects were noted.
Conclusion. PDL treatments provide effective photorejuvenation with minimal risk of side effects. |
---|---|
AbstractList | Background. Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an option in the treatment of photodamage. Although improvements to skin texture are generally modest when compared with ablative resurfacing, PDL offers a treatment with few side effects. A number of methods have been proposed in an effort to improve treatment outcomes. These range from single, low‐fluence treatment with no purpura to multiple passes and treatment sessions as well as purpuric doses.
Objective. To evaluate several of the PDL treatment methods to improve photorejuvenation outcomes while limiting the risk of side effects.
Methods. Twenty patients with photodamage were separated into two groups. Each group received a series of four single‐pass treatments or four double‐pass treatments at 2‐week intervals. Treatments were done using a 595‐nm PDL (PhotoGenica V‐Star) and a 585‐nm PDL (PhotoGenica V) at a pulse duration of 0.5 ms and a 10‐mm handpiece. Treatment fluences were maintained below the individual's purpuric threshold, ranging from 3 to 4 J/cm2. Photos were taken before treatment and during follow‐up. Efficacy of treatment was based on subjective grading of photos and by patient self‐reporting.
Results. Multiple treatments resulted in improvements to skin tone and texture, including a reduction in the appearance of rhytids and, in particular, improved pigmentary evenness. There was no significant difference between laser or treatment methods. No side effects were noted.
Conclusion. PDL treatments provide effective photorejuvenation with minimal risk of side effects. Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an option in the treatment of photodamage. Although improvements to skin texture are generally modest when compared with ablative resurfacing, PDL offers a treatment with few side effects. A number of methods have been proposed in an effort to improve treatment outcomes. These range from single, low-fluence treatment with no purpura to multiple passes and treatment sessions as well as purpuric doses. To evaluate several of the PDL treatment methods to improve photorejuvenation outcomes while limiting the risk of side effects. Twenty patients with photodamage were separated into two groups. Each group received a series of four single-pass treatments or four double-pass treatments at 2-week intervals. Treatments were done using a 595-nm PDL (PhotoGenica V-Star) and a 585-nm PDL (PhotoGenica V) at a pulse duration of 0.5 ms and a 10-mm handpiece. Treatment fluences were maintained below the individual's purpuric threshold, ranging from 3 to 4 J/cm2. Photos were taken before treatment and during follow-up. Efficacy of treatment was based on subjective grading of photos and by patient self-reporting. Multiple treatments resulted in improvements to skin tone and texture, including a reduction in the appearance of rhytids and, in particular, improved pigmentary evenness. There was no significant difference between laser or treatment methods. No side effects were noted. PDL treatments provide effective photorejuvenation with minimal risk of side effects. BACKGROUNDPulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an option in the treatment of photodamage. Although improvements to skin texture are generally modest when compared with ablative resurfacing, PDL offers a treatment with few side effects. A number of methods have been proposed in an effort to improve treatment outcomes. These range from single, low-fluence treatment with no purpura to multiple passes and treatment sessions as well as purpuric doses. OBJECTIVETo evaluate several of the PDL treatment methods to improve photorejuvenation outcomes while limiting the risk of side effects. METHODSTwenty patients with photodamage were separated into two groups. Each group received a series of four single-pass treatments or four double-pass treatments at 2-week intervals. Treatments were done using a 595-nm PDL (PhotoGenica V-Star) and a 585-nm PDL (PhotoGenica V) at a pulse duration of 0.5 ms and a 10-mm handpiece. Treatment fluences were maintained below the individual's purpuric threshold, ranging from 3 to 4 J/cm2. Photos were taken before treatment and during follow-up. Efficacy of treatment was based on subjective grading of photos and by patient self-reporting. RESULTSMultiple treatments resulted in improvements to skin tone and texture, including a reduction in the appearance of rhytids and, in particular, improved pigmentary evenness. There was no significant difference between laser or treatment methods. No side effects were noted. CONCLUSIONPDL treatments provide effective photorejuvenation with minimal risk of side effects. BACKGROUNDPulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an option in the treatment of photodamage. Although improvements to skin texture are generally modest when compared with ablative resurfacing, PDL offers a treatment with few side effects. A number of methods have been proposed in an effort to improve treatment outcomes. These range from single, low-fluence treatment with no purpura to multiple passes and treatment sessions as well as purpuric doses. OBJECTIVETo evaluate several of the PDL treatment methods to improve photorejuvenation outcomes while limiting the risk of side effects. METHODSTwenty patients with photodamage were separated into two groups. Each group received a series of four single-pass treatments or four double-pass treatments at 2-week intervals. Treatments were done using a 595-nm PDL (PhotoGenica V-Star) and a 585-nm PDL (PhotoGenica V) at a pulse duration of 0.5 ms and a 10-mm handpiece. Treatment fluences were maintained below the individualʼs purpuric threshold, ranging from 3 to 4 J/cm. Photos were taken before treatment and during follow-up. Efficacy of treatment was based on subjective grading of photos and by patient self-reporting. RESULTSMultiple treatments resulted in improvements to skin tone and texture, including a reduction in the appearance of rhytids and, in particular, improved pigmentary evenness. There was no significant difference between laser or treatment methods. No side effects were noted. CONCLUSIONPDL treatments provide effective photorejuvenation with minimal risk of side effects. |
Author | Alvarado, Shea L. Sherr, Evan A. Tanghetti, Emil A. |
AuthorAffiliation | Center for Dermatology and Laser Surgery, Sacramento, California Cynosure, Inc., Chelmsford, Massachusetts |
AuthorAffiliation_xml | – name: Center for Dermatology and Laser Surgery, Sacramento, California – name: Cynosure, Inc., Chelmsford, Massachusetts |
Author_xml | – sequence: 1 givenname: Emil A. surname: Tanghetti fullname: Tanghetti, Emil A. – sequence: 2 givenname: Evan A. surname: Sherr fullname: Sherr, Evan A. – sequence: 3 givenname: Shea L. surname: Alvarado fullname: Alvarado, Shea L. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12828691$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkElPwzAQhS0Eomx_AXLiljJeEjsSHFDLJhWBBD1bbjJpU7IUO1Hpv8ehFVw5WDMev_c8-o7Jft3USMgFhSEFEV8thzRiIhSSRUMGwIcsoUp-7ZGj3_m-70HGIUSUDcixc0sAyhIOh2RAmWIqTugRuX7uyrZYGeeCd4umrbBugyYPXhdN22SmMnMMpq6o50G7wOC1Kx0G4w0GE-PQnpKD3PjJ2a6ekOn93fvoMZy8PDyNbidhKkDxUEYiU4lUGcSpMjzLmeA5VcCyVAiamCiJkxmL81k8k2mU-ScTSVBRkrIcc2P4Cbnc5q5s89mha3VVuBTL0tTYdE5LLsDnCy-UW2FqG-cs5npli8rYjaage3B6qXtAugeke3B6C847z3dfdLMKsz_fjpQXiK1g3ZQtWvdRdmu0eoGmbBcaAASTTIV9Jkh_Df0B7m03O1tR4ua_6-jx2_Sn49-1Bowh |
CitedBy_id | crossref_primary_10_1016_j_anplas_2004_08_009 crossref_primary_10_1111_j_1524_4725_2008_34126_x crossref_primary_10_1002_lsm_20028 crossref_primary_10_1002_lsm_20216 crossref_primary_10_1002_lsm_20238 crossref_primary_10_1002_lsm_20587 crossref_primary_10_1002_lsm_20972 crossref_primary_10_1111_j_1468_3083_2007_02297_x crossref_primary_10_1002_lsm_20134 crossref_primary_10_1016_j_sder_2006_06_007 crossref_primary_10_1002_lsm_20982 crossref_primary_10_1111_j_1524_4725_2007_34063_x crossref_primary_10_1002_lsm_21043 crossref_primary_10_1111_j_1524_4725_2004_30256_x crossref_primary_10_1016_j_det_2008_03_002 crossref_primary_10_1016_j_sder_2008_08_002 crossref_primary_10_1007_s10103_006_0427_5 crossref_primary_10_1111_j_0909_752X_2006_00137_x crossref_primary_10_1111_j_1600_0781_2005_00163_x |
Cites_doi | 10.1016/S0140-6736(95)91989-9 10.1016/S0733-8635(05)70451-4 10.1097/00006534-199811000-00060 10.1080/14628830050516542 10.1067/mjd.2001.116580 10.1002/(SICI)1096-9101(1997)21:1<7::AID-LSM2>3.0.CO;2-U 10.1046/j.1524-4725.2000.0260111060.x 10.1002/lsm.10122 10.1002/(SICI)1096-9101(1999)25:3<229::AID-LSM7>3.3.CO;2-4 10.1097/00000637-199901000-00002 |
ContentType | Journal Article |
Copyright | 2003 by the American Society for Dermatologic Surgery, Inc. |
Copyright_xml | – notice: 2003 by the American Society for Dermatologic Surgery, Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1046/j.1524-4725.2003.29187x |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4725 |
EndPage | 691 |
ExternalDocumentID | 10_1046_j_1524_4725_2003_29187x 12828691 00042728-200307000-00003 DSU29187 |
Genre | article Journal Article |
GroupedDBID | --- --K .3N .GA .GJ .Y3 05W 0R~ 10A 1B1 1OC 29F 31~ 36B 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8L- 8UM 930 A01 A03 AAAAV AAHHS AAHPQ AAIQE AAJCS AAONW AARTV AASCR AAUEB AAZKR ABASU ABBUW ABCQN ABDIG ABEML ABJNI ABOCM ABVCZ ABXVJ ABZAD ACCFJ ACDDN ACEWG ACGFS ACILI ACSCC ACWDW ACWRI ACXJB ACXNZ ACXQS ADGGA ADHPY ADNKB ADZOD AEBDS AEETU AEEZP AENEX AEQDE AFBPY AFDTB AFEXH AFFNX AFSOK AFZJQ AHQNM AHVBC AINUH AIWBW AJAOE AJBDE AJIOK AJNWD AJNYG AJZMW ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AZBYB BAFTC BQLVK BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIWNM DR2 DU5 DUNZO EBS EEVPB EJD EX3 F00 F01 F04 FCALG FEDTE G-S G.N GNXGY GODZA GQDEL H.X HF~ HLJTE HOLLA HVGLF HZ~ IHE IKREB IX1 J0M K48 L-C LC2 LC3 LH4 LP6 LP7 LW6 M41 MK4 N04 N05 N9A NF~ NQ- O9- ODMTH OHYEH OIG OLW OPUJH OUVQU OVD OVDNE OVOZU OXXIT P0- P2P P2X P2Z P4B P4D Q.N Q11 QB0 R.K RIG RLZ ROL RPZ RX1 SUPJJ TEORI TSPGW UB1 UDS W8V W99 WOW WQJ WRC WXI WYUIH XG1 YFH ZGI ZXP ZZMQN ~IA ~WT - 0R 31 33P 3N AAPBV ABFLS ABPTK AEUQT BFHJK GA GJ HZ IA IPNFZ K NF OJAPA P4A WT Y3 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4083-754d8978d06c8a3df243f1802dc4419a5969b26fb6b7c5df18a570859c2fefaa3 |
IEDL.DBID | DR2 |
ISSN | 1076-0512 |
IngestDate | Sat Aug 17 03:46:03 EDT 2024 Fri Aug 23 01:17:04 EDT 2024 Sat Sep 28 08:39:31 EDT 2024 Thu Apr 28 07:30:09 EDT 2022 Sat Aug 24 01:05:10 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4083-754d8978d06c8a3df243f1802dc4419a5969b26fb6b7c5df18a570859c2fefaa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 12828691 |
PQID | 73409784 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_73409784 crossref_primary_10_1046_j_1524_4725_2003_29187x pubmed_primary_12828691 wolterskluwer_health_00042728-200307000-00003 wiley_primary_10_1046_j_1524_4725_2003_29187x_DSU29187 |
PublicationCentury | 2000 |
PublicationDate | July 2003 2003-July 2003-Jul 2003-07-00 20030701 |
PublicationDateYYYYMMDD | 2003-07-01 |
PublicationDate_xml | – month: 07 year: 2003 text: July 2003 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: United States |
PublicationTitle | Dermatologic surgery |
PublicationTitleAlternate | Dermatol Surg |
PublicationYear | 2003 |
Publisher | Blackwell Science Inc by the American Society for Dermatologic Surgery, Inc |
Publisher_xml | – name: Blackwell Science Inc – name: by the American Society for Dermatologic Surgery, Inc |
References | McCraw JB (b7_24) 1999; 42 Kilmer SL (b13_30) 1997; 9 b11_28 b12_29 Alster TS (b3_20) 1998; 102 b10_27 b2_19 b1_18 b9_26 b4_21 b5_22 b6_23 b8_25 b14_31 |
References_xml | – ident: b4_21 doi: 10.1016/S0140-6736(95)91989-9 – ident: b5_22 doi: 10.1016/S0733-8635(05)70451-4 – volume: 102 start-page: 2190 year: 1998 ident: b3_20 publication-title: Plast Reconstr Surg doi: 10.1097/00006534-199811000-00060 contributor: fullname: Alster TS – ident: b10_27 doi: 10.1080/14628830050516542 – ident: b11_28 doi: 10.1067/mjd.2001.116580 – ident: b8_25 doi: 10.1002/(SICI)1096-9101(1997)21:1<7::AID-LSM2>3.0.CO;2-U – ident: b9_26 – volume: 9 start-page: 44 year: 1997 ident: b13_30 publication-title: Lasers Surg Med contributor: fullname: Kilmer SL – ident: b6_23 doi: 10.1046/j.1524-4725.2000.0260111060.x – ident: b14_31 doi: 10.1002/lsm.10122 – ident: b1_18 doi: 10.1002/(SICI)1096-9101(1999)25:3<229::AID-LSM7>3.3.CO;2-4 – ident: b2_19 – ident: b12_29 – volume: 42 start-page: 7 year: 1999 ident: b7_24 publication-title: Ann Plast Surg doi: 10.1097/00000637-199901000-00002 contributor: fullname: McCraw JB |
SSID | ssj0012930 |
Score | 1.9461229 |
Snippet | Background. Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has... BACKGROUNDPulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has... Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has become an... |
SourceID | proquest crossref pubmed wolterskluwer wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 686 |
SubjectTerms | Adult Aged Face Female Humans Low-Level Light Therapy - instrumentation Middle Aged Pigmentation Disorders - radiotherapy Rhytidoplasty - instrumentation Skin Aging Statistics, Nonparametric Treatment Outcome Ultraviolet Rays - adverse effects |
Title | Multipass Treatment of Photodamage Using the Pulse Dye Laser |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1524-4725.2003.29187x http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00042728-200307000-00003 https://www.ncbi.nlm.nih.gov/pubmed/12828691 https://search.proquest.com/docview/73409784 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEB1KDqWlpG2atO5XdOhVi9eWJRl6Kd0uoTRlSbOQm5EsmbBL7JDdJSS_vjOSnSZtDyX0ZrCRkGY08-SZeQPwAVF8LWvreF44w0Xpc24K1XB0tdb4xsvYveHwuzyYi68nxUlPKUS1MJEf4uaHG52MYK_pgBsbu5Ckgd12Qa17BBcqKwKt5ygrx1oRnCRaPYJHRzdEUuTUIi-Bwvsz-rgh0yvGN_82zl0_9Qf4HLDsY3hy2VFce7UMae23nNP0KSyGZcWclOVos7aj-vo3xsf_su5nsN1DWPYp6txzeODbHXh42AfpX8DHUNR7jqicHQ9p7Kxr2Oy0W3fOnKEFYyFTgSH4ZLMNOmc2ufLsGzrUi12YT78cfz7gfZMGXguEb1wVwmm8irpU1trkrslE3hCtnKsRaZWmKGVpM9lYaVVdOHyFukCsanXW-MaYfA-22q71r4Cl-J3UohhrS-ykTutxmlqbGWeUkFonkA4iqc4jF0cVYuiC6s1oVyraFeqsmVdxVxLYH0RX4bmhYIhpfbdZVSonpi8tEngZJfprSLqFynKcgAxy-Ne5qsmPeXhKgN_RiSqWtFKcX2QqC5aJTG2s6U_z1_ed6A08CrmFIXv4LWytLzb-HWKktX0f1P8nGbf-aw |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_kBD8QP0-vfl0efM3aTZM0BV_E9Vh19zh0F-6tJE2KsLg97naR8693JmlPT30Q8a3QkpBMJvNL5ze_ALxAFN_oxnleKG-5rELBrSpbjqHW2dAGnW5vmB_q6VK-P1bHPf-JamGSPsTFDzfyjLhfk4PTD-mXfVoyebkSkstSqKjrORLV2JSIJ6-i8yty0snHCykpCmtJmaDEEzRGuYHrlTKcf2rocqT6DX4OaPYm3PraUWb7bBWJ7T-Fp4M7sBoGllgpq9F240bNt180H__PyO_C7R7Fstdp2d2DK2F9H67N-zz9A3gV63pPEJizxcBkZ13Ljj53m87bL7iJsUhWYIg_2dEW4zObnAc2w5h6ugvLg7eLN1Pe39PAG4kIjpdKeoOnUZ_rxtjCt0IWLSnL-QbBVmVVpSsndOu0Kxvl8RUuBxJWa0QbWmuLh7Cz7tZhD1iO32kj1dg4Eij1xozz3DlhvS2lNiaDfLBJfZLkOOqYRpdUckazUtOs0OWaRZ1mJYP9wXY1ug7lQ-w6dNuzuixI7MvIDB4lk_5okg6iuhpnoKMh_ravevJpGZ8y4JcWRZ2qWinVL0Up4uZEu20q68-Lx__a0T5cny7ms3r27vDDE7gRqYaRTPwUdjan2_AMIdPGPY--8B0vzgKa |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEB-kQlGK39a1avPga869fC_0RXoeVdtyaA_6FpJNgli8Pdo7RP_65mO3WvVBxLeFXRKSycz8ZmfmF4CXEcW3orUOU-4MZo2n2HAZcHS11vjgRbm94ehYHMzZu1N-2lMKpV6Ywg9x9cMtaUa210nBly686rOSRck5YZhJwjOt54g0YyUjnLzJBCUpDpt8uGKSSl6tEBPIGEBHJzeUepUE558Guu6ofkOfA5i9DVtfu5TYvjjLde0_eafpXfg8rKsUpZyN1is7ar__Qvn4XxZ-D-70GBa9LofuPtzwiwewedRn6R_CXu7qXUZYjk6GOnbUBTT71K06Z75EE4ZyqQKK6BPN1tE7o8k3jw6jRz1_BPPpm5P9A9zf0oBbFvEblpw5FWNRV4tWGeoCYTQkXjnXRqjVGN6IxhIRrLCy5S6-ioch0aq1JPhgDH0MG4tu4Z8AquN3QjE-VjbRkzqlxnVtLTHOSCaUqqAeRKKXhYxD5yQ6Sw1naVd02pV0tSbVZVcq2B1Ep6PipGyIWfhufaElTVRfilWwXST6Y8gUhopmXIHIcvjbufTk4zw_VYCvnQldelpTop8RSbJpSra2NPXX9Om_TrQLm7PJVB--PX6_A7dynWGuJH4GG6vztX8e8dLKvsiacAkLdgFJ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multipass+Treatment+of+Photodamage+Using+the+Pulse+Dye+Laser&rft.jtitle=Dermatologic+surgery&rft.au=Tanghetti%2C+Emil+A.&rft.au=Sherr%2C+Evan+A.&rft.au=Alvarado%2C+Shea+L.&rft.date=2003-07-01&rft.issn=1076-0512&rft.eissn=1524-4725&rft.volume=29&rft.issue=7&rft.spage=686&rft.epage=691&rft_id=info:doi/10.1046%2Fj.1524-4725.2003.29187x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1046_j_1524_4725_2003_29187x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-0512&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-0512&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-0512&client=summon |